Contrast-induced acute kidney injury (CI-AKI) is a common cause of hospital-acquired acute kidney injury (AKI). We evaluated the evidence that uric acid (UA) plays a pathogenic role in CI-AKI. Ten studies were eligible for inclusion for meta-analysis. Hyperuricemia predicted risk for cases with AKI in prospective cohort studies. Higher levels of serum UA (SUA), as defined by the authors, were associated with a 2-fold increased risk to develop AKI (pooled odds ratio 2.03; 95% confidence interval [CI] 1.48-2.78). Significant heterogeneity was found in cohort studies (P = .001, I2 = 85.7%). In 2 clinical trials, lowering of SUA with saline hydration was significantly associated with reduced risk for AKI compared with saline hydration alone or saline hydration with N-acetyl cysteine. An analysis of 2 randomized controlled trials found that allopurinol with saline hydration had a significant protective effect on renal function (assessed by serum creatinine values) compared with hydration alone (mean difference: −0.52 mg/dL; 95% CI: −0.81 to −0.22). Hyperuricemia independently predicts CI-AKI. Two clinical trials suggest lowering SUA may prevent CI-AKI. The mechanism by which UA induces CI-AKI is likely related to acute uricosuria.
KeaneyJJHannonCMMurrayPT. Contrast-induced acute kidney injury: how much contrast is safe?Nephrol Dial Transpl. 2013;28(6):1376–1383.
2.
MorcosSKThomsenHSWebbJA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999;9(8):1602–1613.
3.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Contrast-Induced nephropathy: an “all or none” phenomenon?Angiology. 2015;66(6):508–513.
4.
NicolaRShaqdanKWAranKMansouriMSinghAAbujudehHH. Contrast-induced nephropathy: identifying the risks, choosing the right agent, and reviewing effective prevention and management methods. Curr Probl Diagn Radiol. 2015;44(6):501–504.
5.
ChenSPCheungWHengCKJordanSCYapHK. Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production. Clin Exp Immunol. 2003;134(1):111–119.
6.
TsimberidouAMKeatingMJ. Hyperuricemic syndromes in cancer patients. Contrib Nephrol. 2005;147:47–60.
7.
EjazAABeaverTMShimadaM. Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients?Am J Nephrol. 2009;30(5):425–429.
LapsiaVJohnsonRJDassB. Elevated uric acid increases the risk for acute kidney injury. Am J Med. 2012;125(3):302.e309–e317.
10.
RoncalCAMuWCrokerB. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol. 2007;292(1):F116–F122.
11.
EjazAADassBLingegowdaV. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urol Nephrol. 2013;45(2):449–458.
12.
BarbieriLVerdoiaMSchafferA. Uric acid levels and the risk of contrast induced nephropathy in patients undergoing coronary angiography or PCI. Nutr Metab Cardiovasc Dis. 2015;25(2):181–186.
13.
LiuYTanNChenJ. The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine. Clinics (Sao Paulo). 2013;68(1):19–25.
14.
ToprakOCiritMEsiEPostaciNYesilMBayataS. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006;67(2):227–235.
15.
KowalczykJFrancuzPSwobodaR. Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clin Pract. 2010;116(2):c114–c122.
16.
ToprakOCiritMYesilM. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007;22(3):819–826.
17.
ElbasanZSahinDYGurM. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 2014;65(1):37–42.
18.
SaritemurMTurkeliMKalkanKTanbogaIHAksakalE. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED. Am J Emerg Med. 2014;32(2):119–123.
19.
ParkSHShinWYLeeEY. The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J. 2011;75(3):692–697.
20.
OkinoSFukuzawaSInagakiM. Hyperuricemia as a risk factor for progressive renal insufficiency after coronary intervention in patients with chronic kidney disease. Cardiovascr Intervention Therap. 2010;25(2):105–111.
21.
KarabulutASahinIIlker AvciI. Impact of serum alkaline phosphatase level on the pathophysiologic mechanism of contrast-induced nephropathy. Kardiol Pol. 2014;72(10):977–982.
22.
ErolTTekinAKatircibasiMT. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. Int J Cardiol. 2013;167(4):1396–1399.
23.
KumarABhawaniGKumariNMurthyKSLalwaniVRaju ChN. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagn Res. 2014;8(12):HC03–HC07.
24.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
25.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
26.
EggerMDavey SmithGSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
27.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
28.
MendiMAAfsarBOksuzF. Uric acid is a useful tool to predict contrast-induced nephropathy [published online March 22, 2016]. Angiology. 2016. doi:https://doi.org/10.1177/0003319716639187
29.
GuoWLiuYChenJY. Hyperuricemia is an independent predictor of contrast-induced acute kidney injury and mortality in patients undergoing percutaneous coronary intervention. Angiology. 2015;66(8):721–726.
30.
KelleyWN. Uricosuria and x-ray contrast agents. N Engl J Med. 1971;284(17):975–976.
31.
PostlethwaiteAEKelleyWN. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations. Ann Intern Med. 1971;74(6):845–852.
32.
SchepersMSvan BallegooijenESBangmaCHVerkoelenCF. Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells. Kidney Int. 2005;68(4):1543–1553.
33.
RyuESKimMJShinHS. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol. 2013;304(5): F471–F480.
34.
HanHJLimMJLeeYJLeeJHYangISTaubM. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB. Am J Physiol Renal Physiol. 2007;292(1):F373–F381.
35.
VerzolaDRattoEVillaggioB. Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4. PloS One. 2014;9(12):e115210.
KanbayMHuddamBAzakA. A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8):1887–1894.
39.
KanbayMSiriopolDNistorI. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol. 2014;39(4):348–356.
40.
KangDHParkSKLeeIKJohnsonRJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–3562.
41.
KanellisJWatanabeSLiJH. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–1293.
42.
CirilloPGerschMSMuW. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol. 2009;20(3):545–553.
43.
Roncal-JimenezCAGarcia-TrabaninoRBarregardL. Heat stress nephropathy from exercise-induced uric acid crystalluria: a perspective on Mesoamerican nephropathy. Am J Kidney Dis. 2016;67(1):20–30.
